SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Hamlin who wrote (991)11/10/1998 10:26:00 AM
From: Charles Salski  Read Replies (1) of 1185
 
Kevin,

This maybe a hint <<< Nortran Completes Phase II Clinical Trial>>>

<<<The final reports on the trial results are expected by mid October. The data will provide a foundation for further licensing discussions on RSD921 with pharmaceutical companies in other areas of the world, and will be the basis for phase III clinical trials. >>>

Regards,
Charles

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News